Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Other Operating Expenses (2022 - 2023)

Historic Other Operating Expenses for Immuneering (IMRX) over the last 2 years, with Q4 2023 value amounting to $7317.0.

  • Immuneering's Other Operating Expenses rose 1.37% to $7317.0 in Q4 2023 from the same period last year, while for Sep 2024 it was $7317.0, marking a year-over-year decrease of 7499.91%. This contributed to the annual value of $29267.0 for FY2023, which is 261.54% down from last year.
  • Latest data reveals that Immuneering reported Other Operating Expenses of $7317.0 as of Q4 2023, which was up 1.37% from $7317.0 recorded in Q3 2023.
  • Immuneering's Other Operating Expenses' 5-year high stood at $8103.0 during Q1 2022, with a 5-year trough of $7316.0 in Q4 2022.